Thomas Kenney

542 total citations
22 papers, 437 citations indexed

About

Thomas Kenney is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas Kenney has authored 22 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas Kenney's work include Estrogen and related hormone effects (6 papers), Cystic Fibrosis Research Advances (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Thomas Kenney is often cited by papers focused on Estrogen and related hormone effects (6 papers), Cystic Fibrosis Research Advances (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Thomas Kenney collaborates with scholars based in United States, Canada and Australia. Thomas Kenney's co-authors include David L. MacLeod, William R. Baker, L. M. Barker, Jesse L. Gurgel, Jane L. Burns, Susan Chippari, Noreen Henig, Gregory G. Anderson, George A. O’Toole and Richard C. Winneker and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Thomas Kenney

21 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Kenney United States	12	136	90	86	84	64	22	437
Franklin W. Okumu United States	9	317 2.3×	49 0.5×	21 0.2×	25 0.3×	63 1.0×	12	644
P. Bronwen Loder Australia	13	158 1.2×	38 0.4×	34 0.4×	40 0.5×	27 0.4×	19	497
Yumiko Kanda Japan	13	167 1.2×	91 1.0×	23 0.3×	6 0.1×	26 0.4×	23	422
Catherine Piveteau France	12	220 1.6×	94 1.0×	32 0.4×	37 0.4×	82 1.3×	25	496
Zhiling Li China	10	255 1.9×	26 0.3×	43 0.5×	7 0.1×	37 0.6×	25	726
Hideo Shirafuji Japan	10	219 1.6×	44 0.5×	96 1.1×	22 0.3×	29 0.5×	17	464
Kiyean Nam United States	11	237 1.7×	115 1.3×	22 0.3×	23 0.3×	77 1.2×	24	458
Michael Vicchiarelli United States	10	121 0.9×	55 0.6×	5 0.1×	61 0.7×	64 1.0×	17	349
Seema Husain United States	12	219 1.6×	29 0.3×	26 0.3×	42 0.5×	152 2.4×	21	511
Abderrazzak Bentaher France	11	156 1.1×	49 0.5×	83 1.0×	15 0.2×	38 0.6×	22	514

Countries citing papers authored by Thomas Kenney

Since Specialization

Citations

This map shows the geographic impact of Thomas Kenney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kenney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kenney more than expected).

Fields of papers citing papers by Thomas Kenney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kenney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kenney. The network helps show where Thomas Kenney may publish in the future.

Co-authorship network of co-authors of Thomas Kenney

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kenney. A scholar is included among the top collaborators of Thomas Kenney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kenney. Thomas Kenney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matson, Clinton K., Thomas Kenney, Bart Steiner, et al.. (2022). Abstract 3696: GS-9716: A potent, selective and orally bioavailable small molecule inhibitor of MCL1 for the treatment of cancer. Cancer Research. 82(12_Supplement). 3696–3696. 3 indexed citations

Laplante, David P., Thomas Kenney, Guillaume Elgbeili, et al.. (2022). Elemental analysis of hair provides biomarkers of maternal hardship linked to adverse behavioural outcomes in 4-year-old children: The QF2011 Queensland Flood Study. Journal of Trace Elements in Medicine and Biology. 73. 127036–127036. 10 indexed citations

Ji, Shaoyi, et al.. (2021). Distinct expression of select and transcriptome-wide isolated 3’UTRs suggests critical roles in development and transition states. PLoS ONE. 16(5). e0250669–e0250669. 5 indexed citations

Dai, Wei, et al.. (2017). Quantitative microscopy of the Drosophila ovary shows multiple niche signals specify progenitor cell fate. Nature Communications. 8(1). 1244–1244. 26 indexed citations

Perreault, Stéphane, Jayaraman Chandrasekhar, Zhi-Hua Cui, et al.. (2017). Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856. Journal of Medicinal Chemistry. 60(4). 1555–1567. 27 indexed citations

Unwalla, Ray, James J. Mousseau, Olugbeminiyi Fadeyi, et al.. (2017). Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators. Journal of Medicinal Chemistry. 60(14). 6451–6457. 14 indexed citations

Bates, Jamie, Saritha Kusam, Stacey Tannheimer, et al.. (2016). Combination of the BET Inhibitor GS-5829 and a BCL2 Inhibitor Resulted in Broader Activity in DLBCL and MCL Cell Lines. Blood. 128(22). 5104–5104. 2 indexed citations

Chekler, Eugene L. Piatnitski, M. Catherine Johnson, James T. Anderson, et al.. (2014). 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators. Journal of Medicinal Chemistry. 57(6). 2462–2471. 13 indexed citations

Anderson, Gregory G., Thomas Kenney, David L. MacLeod, Noreen Henig, & George A. O’Toole. (2013). Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination. PMC. 1 indexed citations

10.

MacLeod, David L., et al.. (2012). Fosfomycin Enhances the Active Transport of Tobramycin in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 56(3). 1529–1538. 37 indexed citations

11.

Anderson, Gregory G., Thomas Kenney, David L. MacLeod, Noreen Henig, & George A. O’Toole. (2012). Eradication ofPseudomonas aeruginosabiofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination. Pathogens and Disease. 67(1). 39–45. 42 indexed citations

12.

Crabtree, Judy S., Edward J. Kilbourne, Susan Chippari, et al.. (2010). A Mouse Model of Androgenetic Alopecia. Endocrinology. 151(5). 2373–2380. 46 indexed citations

13.

MacLeod, David L., L. M. Barker, Jesse L. Gurgel, et al.. (2009). Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. Journal of Antimicrobial Chemotherapy. 64(4). 829–836. 88 indexed citations

14.

Manas, Eric S., Robert McDevitt, Yanfang Li, et al.. (2009). Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles. Bioorganic & Medicinal Chemistry. 17(22). 7802–7815. 29 indexed citations

15.

Ho, Douglas M., Christina M. Kraml, Eugene J. Trybulski, et al.. (2007). Estrogen Receptor Dependent Inhibitors of NF-κB Transcriptional Activation-1 Synthesis and Biological Evaluation of Substituted 2-Cyanopropanoic Acid Derivatives: Pathway Selective Inhibitors of NF-κB, a Potential Treatment for Rheumatoid Arthritis. Journal of Medicinal Chemistry. 50(22). 5245–5248. 12 indexed citations

16.

Steffan, Robert J., Edward Matelan, Mark A. Ashwell, et al.. (2006). Control of Chronic Inflammation with Pathway Selective Estrogen Receptor Ligands. Current Topics in Medicinal Chemistry. 6(2). 103–111. 11 indexed citations

17.

Harnish, Douglas C., Xiaorong Liu, Thomas Kenney, et al.. (2006). The Pathway-selective Estrogen Receptor Ligand WAY-169916 Displays Differential Activity in Ischemia-Reperfusion Injury Models. Journal of Cardiovascular Pharmacology. 47(6). 788–795. 7 indexed citations

18.

Steffan, Robert J., Edward Matelan, Mark A. Ashwell, et al.. (2004). Synthesis and Activity of Substituted 4-(Indazol-3-yl)phenols as Pathway-Selective Estrogen Receptor Ligands Useful in the Treatment of Rheumatoid Arthritis. Journal of Medicinal Chemistry. 47(26). 6435–6438. 59 indexed citations

19.

Hubert, Lawrence J., R. G. Golledge, Thomas Kenney, & C. Michael Costanzo. (1982). Evaluating Classification Schemes Used in Reporting Criminal Justice Data. Evaluation Review. 6(4). 505–520. 1 indexed citations

20.

Hubert, Lawrence J., Thomas Kenney, R. G. Golledge, & C. Michael Costanzo. (1981). Aggregation in Data Tables: Implications for Evaluating Criminal Justice Statistics. Environment and Planning A Economy and Space. 13(2). 185–199. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact